CoChat

Beta-Blocker Therapy in Advanced Heart Failure: Clinical Characteristics and Long-Term Outcomes

Open access
O’Connor, Christopher M., Gattis, Wendy A., Zannad, Faiez, McNulty, Steven E., Gheorghiade, Mihai, Adams, Kirkwood F., Califf, Robert M., McKenna, William J., Soler-Soler, Jordi, Swedberg, Karl · 1999 · European Journal of Heart Failure
Cited by 16

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Aims: To evaluate the clinical characteristics and long-term outcomes of advanced heart failure patients (NYHA Class IIIb–IV) receiving beta-blocker therapy vs. those patients not receiving beta-blockers at randomization in the FIRST trial, a randomized, double-blind, placebo-controlled trial of epoprostenol vs. usual care in advanced heart failure. Methods and results: The patient population consisted of 471 patients enrolled in FIRST with Class IIIb–IV heart failure, left ventricular ejection fraction (LVEF) of < 30%, advanced hemodynamic abnormalities, and standard pharmacologic treatment of ACE-inhibitor, diuretics, and/or digoxin. The study cohort consisted of 448 patients not receiving beta-blockers and 23 patients receiving beta-blockers at randomization for the FIRST trial. Patients in the beta-blocker group had decreased rates of any clinical event (P = 0.03), worsening heart failure (P = 0.001), and death or worsening heart failure (P = 0.0008) than patients not receiving beta-blockers. After adjusting for prognostically important variables, the favorable effect of beta-blockers on worsening heart failure (P = 0.02) and death or worsening heart failure (P = 0.02) persisted. Conclusion: Patients with advanced heart failure who receive beta-blocker therapy have a lower rate of hospitalization and are less likely to experience worsening heart failure or death at 6 months than patients who are not treated with beta-blockers. These observational data contribute to the growing body of data demonstrating a favorable effect of beta-blockers on clinical outcomes in heart failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1388-9842(98)00004-x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 16

Metadata

Authors
O’Connor, C. M., Gattis, W. A., Zannad, F., McNulty, S. E., Gheorghiade, M., Adams, K. F., Califf, R. M., McKenna, W. J., Soler-Soler, J., & Swedberg, K.
Venue
European Journal of Heart Failure
Published
1999-03-01
Volume
1
Issue
1
Pages
81-88
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W1988910988
Cited by
16
References
1
FWCI
1.13
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Beta-Blocker Therapy in Advanced Heart Failure: Clinical Characteristics and Long-Term Outcomes. https://app.cochat.ai/papers/10.1016/s1388-9842(98)00004-x
The paper
O’Connor, C. M., Gattis, W. A., Zannad, F., McNulty, S. E., Gheorghiade, M., Adams, K. F., Califf, R. M., McKenna, W. J., Soler-Soler, J., & Swedberg, K. (1999). Beta-Blocker Therapy in Advanced Heart Failure: Clinical Characteristics and Long-Term Outcomes. European Journal of Heart Failure. https://doi.org/10.1016/s1388-9842(98)00004-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.